Elon Musk's brain implant company Neuralink says the FDA has approved human trials
May 26, 2023 at 05:45
Neuralink has announced that the U.S. Food and Drug Administration (FDA) has approved the launch of its first clinical study in humans.
"We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!"
The neurotechnology company isn't recruiting test subjects just yet, and hasn't released any information on exactly what the clinical trial will involve.
Even so, fans of Neuralink founder Elon Musk are already chomping(opens in a new tab) at(opens in a new tab) the(opens in a new tab) bit(opens in a new tab) to implant questionable experimental technology in their grey matter.
Neuralink aims to develop implantable devices that will let people control computers with their brain, as well as restore vision or mobility to people with disabilities.
However, while this may sound exciting for people with disabilities, there are serious concerns about Neuralink's brain chips.
The FDA reportedly rejected a previous application from Neuralink to begin human trials last year, as there were "dozens of issues the company must address."
Among them were concerns that wires could shift and damage the brain, that the brain might be damaged during removal of the device, and that there may be potential issues with its lithium battery.
Neuralink is also currently under investigation for animal welfare violations, with reports of botched experiments resulting in needless suffering and death.
This has allegedly included instances of surgeons using the wrong surgical tools, implanting Neuralink devices in incorrect locations, and implanting devices that were the wrong size.
Musk has spent years claiming that Neuralink would soon begin human trials.
If this latest announcement is true, it might actually finally happen this time.